Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer REPLY

被引：0
|
作者：
Shahinian, Vahakn B. [1 ]
Kuo, Yong-Fang [2 ]
Gilbert, Scott M. [3 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Texas Med Branch, Galveston, TX USA
[3] Univ Florida, Gainesville, FL USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 06期
关键词：
RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：580 / 580
页数：1
相关论文
共 50 条
  • [21] Regarding Sequencing of Androgen-Deprivation Therapy Reply
    Martin, Ting
    Sun, Yilun
    Spratt, Daniel E.
    Kishan, Amar U.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (13)
  • [22] Re: Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
    不详
    JOURNAL OF UROLOGY, 2021, 205 (01): : 303 - 304
  • [23] Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer
    Alberga, Angela S.
    Segal, Roanne J.
    Reid, Robert D.
    Scott, Chris G.
    Sigal, Ronald J.
    Khandwala, Farah
    Jaffey, James
    Wells, George A.
    Kenny, Glen P.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (05) : 971 - 981
  • [24] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
    C Jin
    Y Fan
    Y Meng
    C Shen
    Y Wang
    S Hu
    C Cui
    T Xu
    W Yu
    J Jin
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 333 - 339
  • [25] Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer
    Niraula, Saroj
    Tannock, Ian F.
    JAMA ONCOLOGY, 2016, 2 (04) : 461 - 462
  • [26] Immediate versus deferred androgen-deprivation therapy for localized prostate cancer
    Nature Clinical Practice Urology, 2006, 3 (7): : 348 - 349
  • [27] Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer
    Chow, Alexander K.
    Vourganti, Srinivas
    Konety, Badrinath R.
    EUROPEAN UROLOGY, 2021, 80 (03) : 386 - 386
  • [28] Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Roe, Kathrine
    Mikalsen, Lars T. G.
    van der Kogel, Albert J.
    Bussink, Johan
    Lyng, Heidi
    Ree, Anne H.
    Marignol, Laure
    Olsen, Dag R.
    RADIATION ONCOLOGY, 2012, 7
  • [29] Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
    Cattrini, Carlo
    Zanardi, Elisa
    Boccardo, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) : 2350 - +
  • [30] Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
    Wolff, Johannes M.
    Abrahamsson, Per-Anders
    Irani, Jacques
    da Silva, Fernando Calais
    BJU INTERNATIONAL, 2014, 114 (04) : 476 - 483
12345